Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)
To access this article, please choose from the options below
This study was supported by the investigators, and no company provided any financial support or drugs free of charge; we have no conflicts of interest to declare.
PII: S0002-9149(09)02829-X
doi:10.1016/j.amjcard.2009.12.001
© 2010 Elsevier Inc. All rights reserved.
